Amylyx Pharmaceuticals
An Associate Director, Regulatory Medical Writing at Amylyx is a senior regulatory communications role supporting the company’s clinical-stage development programs. The position sits within a small biopharmaceutical company focused on PBH, Wolfram syndrome, and ALS and requires strong familiarity with regulatory and clinical development processes. The role is remote within the U.S. with periodic travel to Cambridge, MA.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Associate Director, Medical Writing
Sarepta Therapeutics
Associate Director, Medical Writing
argenx
Director, Medical Writing
Kiniksa Pharmaceuticals
Associate Director - Regulatory and Medical Writing
ionis
Sr. Manager, Medical Writing
Artiva Biotherapeutics
Director, Global Medical Writing
Deciphera Pharmaceuticals